NCT05096676View on ClinicalTrials.gov

Understanding Oxytocin's Neural and Behavioral Effects in Adolescents Diagnosed With Autism

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

August 1, 2016

Primary Completion Date

October 1, 2019

Study Completion Date

October 1, 2019

Conditions
Autism Spectrum DisorderOxytocin
Interventions
DRUG

Oxytocin: Including placebo

Individual received age-dependent dosing of oxytocin and placebo. Participants aged 13-18 years received a dose of 24 IU (3 puffs to each nostril), and younger participants (aged 12 years) received 16 IU.

All Listed Sponsors
lead

Prof. Ilanit gordon

OTHER

NCT05096676 - Understanding Oxytocin's Neural and Behavioral Effects in Adolescents Diagnosed With Autism | Biotech Hunter | Biotech Hunter